Presage Pharmaceuticals Receives FDA Green Light for Landmark CIVO Phase 0 Clinical Trial of Innovative Pre-GMP Drug Candidate

In a groundbreaking development, Presage Pharmaceuticals has officially received approval from the U.S. Food and Drug Administration (FDA) to proceed with a crucial study evaluating their promising pre-GMP drug candidate. The company has been given the green light to initiate the Clinical In Vivo Oncology (CIVO) Phase 0 clinical trial, marking a significant milestone in … Read more